These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15261137)

  • 1. Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes.
    Brugarolas J; Kaelin WG
    Cancer Cell; 2004 Jul; 6(1):7-10. PubMed ID: 15261137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.
    Kwiatkowski DJ; Manning BD
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R251-8. PubMed ID: 16244323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice.
    Ylikorkala A; Rossi DJ; Korsisaari N; Luukko K; Alitalo K; Henkemeyer M; Mäkelä TP
    Science; 2001 Aug; 293(5533):1323-6. PubMed ID: 11509733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.
    Corradetti MN; Inoki K; Bardeesy N; DePinho RA; Guan KL
    Genes Dev; 2004 Jul; 18(13):1533-8. PubMed ID: 15231735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LKB1 tumor suppressor negatively regulates mTOR signaling.
    Shaw RJ; Bardeesy N; Manning BD; Lopez L; Kosmatka M; DePinho RA; Cantley LC
    Cancer Cell; 2004 Jul; 6(1):91-9. PubMed ID: 15261145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
    Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
    J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.
    Forcet C; Etienne-Manneville S; Gaude H; Fournier L; Debilly S; Salmi M; Baas A; Olschwang S; Clevers H; Billaud M
    Hum Mol Genet; 2005 May; 14(10):1283-92. PubMed ID: 15800014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes.
    Mehenni H; Lin-Marq N; Buchet-Poyau K; Reymond A; Collart MA; Picard D; Antonarakis SE
    Hum Mol Genet; 2005 Aug; 14(15):2209-19. PubMed ID: 15987703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the PI3K/Akt, mTOR, and STK11/LKB1 pathways in the tumorigenesis of sclerosing hemangioma of the lung.
    Amin RM; Hiroshima K; Miyagi Y; Kokubo T; Hoshi K; Fujisawa T; Nakatani Y
    Pathol Int; 2008 Jan; 58(1):38-44. PubMed ID: 18067639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts.
    Yen ML; Su JL; Chien CL; Tseng KW; Yang CY; Chen WF; Chang CC; Kuo ML
    Mol Pharmacol; 2005 Oct; 68(4):1061-73. PubMed ID: 15998873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome.
    Shackelford DB; Vasquez DS; Corbeil J; Wu S; Leblanc M; Wu CL; Vera DR; Shaw RJ
    Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11137-42. PubMed ID: 19541609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
    Astrinidis A; Henske EP
    Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.
    Nobukini T; Thomas G
    Novartis Found Symp; 2004; 262():148-54; discussion 154-9, 265-8. PubMed ID: 15562827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated onsets of gastric hamartomas and hepatic adenomas/carcinomas in Lkb1+/-p53-/- compound mutant mice.
    Takeda H; Miyoshi H; Kojima Y; Oshima M; Taketo MM
    Oncogene; 2006 Mar; 25(12):1816-20. PubMed ID: 16278673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis.
    Wei C; Amos CI; Stephens LC; Campos I; Deng JM; Behringer RR; Rashid A; Frazier ML
    Cancer Res; 2005 Dec; 65(24):11297-303. PubMed ID: 16357136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling.
    Wei C; Amos CI; Zhang N; Wang X; Rashid A; Walker CL; Behringer RR; Frazier ML
    Clin Cancer Res; 2008 Feb; 14(4):1167-71. PubMed ID: 18281551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer.
    Carretero J; Medina PP; Blanco R; Smit L; Tang M; Roncador G; Maestre L; Conde E; Lopez-Rios F; Clevers HC; Sanchez-Cespedes M
    Oncogene; 2007 Mar; 26(11):1616-25. PubMed ID: 16953221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling.
    van Veelen W; Korsse SE; van de Laar L; Peppelenbosch MP
    Oncogene; 2011 May; 30(20):2289-303. PubMed ID: 21258412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
    Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
    Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P; Mateo J
    Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.